# Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer

> **NCT00463060** · PHASE1,PHASE2 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 47 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** sunitinib malate (Sutent)
- **PROCEDURE:** radiotherapy

## Key facts

- **NCT ID:** NCT00463060
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2018-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463060, "Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00463060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*